High mobility group box-1 protein acts as a coactivator of nuclear factor of activated T cells-2 in promoting interleukin-2 transcription

International Journal of Biochemistry and Cell Biology

Volumn 41, Issue 3, 2009, Pages 641-648

  Liu, Hui ^b   Yao, Yong ming ^b   Ding, Li hua ^a   Zhang, Hao ^a   Yuan, Bing ^a   Song, Qing ^b   Ye, Qi nong ^a   Huang, Cui fen ^a   Sheng, Zhi yong ^b  

^a BEIJING INSTITUTE OF BIOTECHNOLOGY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

HMGB1; IL 2; Immune; NFAT2; SRNAi

Indexed keywords

HIGH MOBILITY GROUP B1 PROTEIN; INTERLEUKIN 2; NUCLEIC ACID BINDING PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR NFAT2; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; CYTOKINE PRODUCTION; FEMALE; GENETIC TRANSCRIPTION; HELA CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOREGULATION; IN VITRO STUDY; IN VIVO STUDY; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REPORTER GENE; T LYMPHOCYTE; TRANSCRIPTION INITIATION; UPREGULATION;

HELA CELLS; HMGB1 PROTEIN; HUMANS; IMMUNOLOGIC FACTORS; INTERLEUKIN-2; NFATC TRANSCRIPTION FACTORS; PROTEIN BINDING; RESPONSE ELEMENTS; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; TRANSFECTION;

VERTEBRATA;

EID: 58149312606     PISSN: 13572725     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biocel.2008.07.009     Document Type: Article

References (30)

1. Assenberg R., Webb M., Connolly E., Stott K., Watson M., Hobbs J., et al. A critical role in structure-specific DNA binding for the acetylatable lysine residues in HMGB1. The Biochemical Journal 411 (2008) 553-561
2. Barlic J., McDermott D.H., Merrell M.N., Gonzales J., Via L.E., and Murphy P.M. Interleukin (IL)-15 and IL-2 reciprocally regulate expression of the chemokine receptor CX3CR1 through selective NFAT1- and NFAT2-dependent mechanisms. The Journal Biological Chemistry 279 (2004) 48520-48534
3. Bianchi M.E., and Manfredi A.A. High-mobility group box 1 (HMGB1) protein at the crossroads between innate and adaptive immunity. Immunological Reviews 220 (2007) 35-46
4. Boonyaratanakornkit V., Melvin V., Prendergast P., Altmann M., Ronfani L., Bianchi M.E., et al. High-mobility chromatin proteins 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptional activity in mammalian cells. Molecular and Cellular Biology 18 (1998) 4471-4487
5. Brickman J.M., Adam M., and Ptashne M. Interactions between an HMGB-1 protein and members of the Rel family. Proceedings of the National Academy of Sciences of the United States of America 96 (1999) 10679-10683
6. Bustin M.M. Regulation of DNA-dependent activities by the functional motifs of the high mobility group chromosomal proteins. Molecular and Cellular Biology 19 (1999) 5237-5246
7. Butteroni C., De Felici M., Scholer H.R., and Pesce M. Phage display screening reveals an association between germline-specific transcription factor Oct-4 and multiple cellular proteins. Journal of Molecular Biology 304 (2000) 529-540
8. Das D., Peterson R.C., and Scovell W.M. High mobility group B proteins facilitate strong estrogen receptor binding to classical and half-site estrogen response elements and relax binding selectivity. Molecular Endocrinology 18 (2004) 2616-2632
9. Jayaraman L., Moorthy N.C., Murthy K.G., Manley J.L., Bustin M., and Prives C. High mobility group protein-1 is a unique activator of p53. Genes & Development 12 (1998) 462-472
10. Kiani A., García-Cózar F.J., Habermann I., Laforsch S., Aebischer T., Ehninger G., et al. Regulation of interferon-gene expression by nuclear factor of activated T cells. Blood 98 (2001) 1480-1488
11. Li J., Kokkola R., Tabibzadeh S., Yang R., Ochani M., Qiang X., et al. Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Molecular Medicine 9 (2003) 37-45
12. McCauley M.J., Zimmerman J., Maher III L.J., and Williams M.C. HMGB binding to DNA: single and double box motifs. Journal of Molecular Biology 374 (2007) 993-1004
13. Melvin V.S., and Edwards D.P. Coregulatory proteins in steroid hormone receptor action: the role of chromatin high mobility group proteins HMG-1 and -2. Steroids 64 (1999) 576-586
14. Messmer D., Yang H., Telusma G., Knoll F., Li J., Messmer B., et al. High mobility group box protein 1: an endogenous signal for dendritic cell maturation and Th1 polarization. Journal of Immunology 173 (2004) 307-313
15. Mitsouras K., Wong B., Arayata C., Johnson R.C., and Carey M. The DNA architectural protein HMGB1 displays two modes of action that promote enhanceosome assembly. Molecular and Cellular Biology 22 (2002) 4390-4401
16. Müller S., Bianchi M.E., and Knapp S. Thermodynamics of HMG1 interaction with duplex DNA. Biochemistry 40 (2001) 10254-10261
17. Najima Y., Yahagi N., Takeuchi Y., Matsuzaka T., Sekiya M., Nakagawa Y., et al. High mobility group protein-B1 interacts with sterol regulatory element-binding proteins to enhance their DNA binding. The Journal Biological Chemistry 280 (2005) 27523-27532
18. Ner S.S., Travers A.A., and Churchill M.E. Harnessing the writhe: a role for DNA chaperones in nucleoproteincomplex formation. Trends in Biochemical Sciences 19 (1994) 185-187
19. Northrop J.P., Ho S.N., Chen L., Thomas D.J., Timmerman L.A., Nolan G.P., et al. NF-AT components define a family of transcription factors targeted in T-cell activation. Nature 369 (1994) 497-502
20. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., et al. Extracellular HMGB1, a signal of tissue damage, induces mesangioblast migration and proliferation. The Journal of Cell Biology 164 (2004) 441-449
21. Randak C., Brabletz T., Hergenröther M., Sobotta I., and Serfling E. Cyclosporin A suppresses the expression of the interleukin 2 gene by inhibiting the binding of lymphocyte-specific factors to the IL-2 enhancer. The EMBO Journal 9 (1990) 2529-2536
22. Romine L.E., Wood J.R., Lamia L.A., Prendergast P., Edwards D.P., and Nardulli A.M. The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Molecular Endocrinology 12 (1998) 664-674
23. Ross E.D., Hardwidge P.R., and Maher III L.J. HMGB proteins and DNA flexibility in transcription activation. Molecular and Cellular Biology 21 (2001) 6598-6605
24. Rovere-Querini P., Capobianco A., Scaffidi P., Valentinis B., Catalanotti F., Giazzon M., et al. HMGB1 is an endogenous immune adjuvant released by necrotic cells. EMBO Reports 5 (2004) 825-830
25. Shaw J.P., Utz P.J., Durand D.B., Toole J.J., Emmel E.A., and Crabtree G.R. Identification of a putative regulator of early T cell activation genes. Science 241 (1988) 202-205
26. Wang H., Bloom O., Zhang M., Vishnubhakat J.M., Ombrellino M., Che J., et al. HMG-1 as a late mediator of endotoxin lethality in mice. Science 285 (1999) 248-251
27. Webb M., Payet D., Lee K.B., Travers A.A., and Thomas J.O. Structural requirements for cooperative binding of HMG1 to DNA minicircles. Journal of Molecular Biology 309 (2001) 79-88
28. Yang H., Wang H., Czura C.J., and Tracey K.J. The cytokine activity of HMGB1. Journal of Leukocyte Biology 78 (2005) 1-8
29. Ye Q., Chung L.W., Cinar B., Li S., and Zhau H.E. Identification and characterization of estrogen receptor variants in prostate cancer cell lines. The Journal of Steroid Biochemistry and Molecular Biology 75 (2000) 21-31
30. Zappavigna V., Falciola L., Citterich M.H., Mavilio F., and Bianchi M.E. HMG1 interacts with HOX proteins and enhances their DNA binding and transcriptional activation. EMBO Journal 15 (1996) 4981-4991